BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Feb 13 X T L Biopharmaceuticals Ltd
* X T L Biopharmaceuticals - expands clinical advisory board with two experts in rheumatology to support Phase II study of HCDR1 in Sjogren's syndrome Source text for Eikon: Further company coverage:
WASHINGTON, March 28 U.S. President Donald Trump told a group of senators on Tuesday that he expected lawmakers would be able to reach a deal on healthcare, without offering specifics on how they would do it or what had changed since a healthcare reform bill was pulled last week for insufficient support.